Acknowledgments
We gratefully acknowledge the Australasian Association of Clinical Biochemists (AACB) in agreeing to provide financial support for transportation of Bile Acid Comparison and Harmonisation (BACH) samples to participating laboratories servicing Australian TURRIFIC trial recruitment sites.
-
Research funding: None declared.
-
Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.
-
Competing interests: Authors state no conflict of interest.
-
Informed consent: Not applicable.
-
Ethical approval: Ethical approval for the study has been granted by the Women’s and Children’s Hospital Human Research Ethics Committee (HREC/18/WCHN/36).
References
1. de Aguiar Vallim, TQ, Tarling, EJ, Edwards, PA. Pleiotropic roles of bile acids in metabolism. Cell Metabol 2013;17:657–69. https://doi.org/10.1016/j.cmet.2013.03.013.Search in Google Scholar PubMed PubMed Central
2. Mitchell, AL, Ovadia, C, Syngelaki, A, Souretis, K, Martineau, M, Girling, J, et al.. Re-evaluating diagnostic thresholds for intrahepatic cholestasis of pregnancy: case-control and cohort study. BJOG 2021;128:1635–44. https://doi.org/10.1111/1471-0528.16669.Search in Google Scholar PubMed
3. Ovadia, C, Seed, PT, Sklavounos, A, Geenes, V, Di Ilio, C, Chambers, J, et al.. Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses. Lancet 2019;393:899–909. https://doi.org/10.1016/s0140-6736(18)31877-4.Search in Google Scholar
4. Hague, WM, Jeffries, B, Chenia, F, Parange, A, Wilkinson, C. South Australian perinatal practice guideline: intrahepatic cholestasis of pregnancy [Internet]. Government of South Australia: Department for Health and Wellbeing. Available from: https://www.sahealth.sa.gov.au/wps/wcm/connect/f91fbf004ee530b2a5ebadd150ce4f37/obstetric+cholestasis_27042016.pdf?MOD=AJPERES [Accessed 25 Apr 2022].Search in Google Scholar
5. Hague, WM, Callaway, L, Chambers, J, Chappell, L, Coat, S, de Haan-Jebbink, J, et al.. A multi-centre, open label, randomised, parallel-group, superiority Trial to compare the efficacy of URsodeoxycholic acid with RIFampicin in the management of women with severe early onset Intrahepatic Cholestasis of pregnancy: the TURRIFIC randomised trial. BMC Pregnancy Childbirth 2021;21:51. https://doi.org/10.1186/s12884-020-03481-y.Search in Google Scholar PubMed PubMed Central
6. Markus, C, Coat, S, Marschall, HU, Williamson, C, Dixon, P, Fuller, M, et al.. The BACH project protocol: an international multicentre total bile acid comparison and Harmonisation project and sub-study of the TURRIFIC randomised trial. Clin Chem Lab Med 2021;59:1921–9. https://doi.org/10.1515/cclm-2021-0496.Search in Google Scholar PubMed
7. Therapeutic goods administration: urgent medical device recall (Reference: RC-2022-RN-00353-1) [Internet]. Australian Government: Therapeutic Goods Administration, Department of Health; 2022. Available from: https://apps.tga.gov.au/Prod/sara/arn-detail.aspx?k=RC-2022-RN-00353-1 [Accessed 2022 Apr 25].Search in Google Scholar
8. Algeciras-Schimnich, A, Bruns, DE, Boyd, JC, Bryant, SC, La Fortune, KA, Grebe, SK. Failure of current laboratory protocols to detect lot-to-lot reagent differences: findings and possible solutions. Clin Chem 2013;59:1187–94. https://doi.org/10.1373/clinchem.2013.205070.Search in Google Scholar PubMed
9. Koerbin, G, Liu, J, Eigenstetter, A, Tan, CH, Badrick, T, Loh, TP. Missed detection of significant positive and negative shifts in gentamicin assay: implications for routine laboratory quality practices. Biochem Med 2018;28:010705. https://doi.org/10.11613/bm.2018.010705.Search in Google Scholar PubMed PubMed Central
10. Loh, TP, Sandberg, S, Horvath, AR. Lot-to-lot reagent verification: challenges and possible solutions. Clin Chem Lab Med 2022;60:675–80. https://doi.org/10.1515/cclm-2022-0092.Search in Google Scholar PubMed
© 2023 Walter de Gruyter GmbH, Berlin/Boston
